Cargando…

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

BACKGROUND: CD58 has been demonstrated to be abnormally expressed in multiple hematopoietic malignancies and solid tumors and plays an essential role in tumorigenesis and progression; however, its clinical significance and prognostic value in pancreatic ductal adenocarcinoma (PDAC) remain unknown. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yalu, Liu, Qiaofei, Liu, Jingkai, Liao, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243423/ https://www.ncbi.nlm.nih.gov/pubmed/34193136 http://dx.doi.org/10.1186/s12935-021-02037-0

Ejemplares similares

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
por: Liu, Jingkai, et al.
Publicado: (2021)

CD58 Immunobiology at a Glance
por: Zhang, Yalu, et al.
Publicado: (2021)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Cui, Ming, et al.
Publicado: (2020)

Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2022)

Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis
por: Li, Tong, et al.
Publicado: (2020)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum
por: Cui, Ming, et al.
Publicado: (2021)

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
por: Yang, Sen, et al.
Publicado: (2022)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming
por: Yang, Sen, et al.
Publicado: (2021)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
por: Wang, Xing, et al.
Publicado: (2020)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

Up‐regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma
por: Gao, Junyi, et al.
Publicado: (2020)

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)

SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
por: Zhang, Wei, et al.
Publicado: (2015)

Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition
por: Zhang, Zhiwen, et al.
Publicado: (2019)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma
por: Wang, Dong, et al.
Publicado: (2018)

Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma
por: Gao, Wei, et al.
Publicado: (2020)

Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
por: Park, Sejun, et al.
Publicado: (2023)

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
por: Liu, Liya, et al.
Publicado: (2021)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
por: Huo, Yanmiao, et al.
Publicado: (2015)

LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
por: Wu, Liping, et al.
Publicado: (2020)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
por: Dai, Chen, et al.
Publicado: (2020)

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
por: Albahde, Mugahed Abdullah Hasan, et al.
Publicado: (2020)

Long noncoding RNA: a dazzling dancer in tumor immune microenvironment
por: Zhang, Yalu, et al.
Publicado: (2020)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Han, Hailin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e56a0h1v2i9lsbiic3e9glhsol